These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


91 related items for PubMed ID: 23886949

  • 21. Public health impact of neovascular age-related macular degeneration treatments extrapolated from visual acuity.
    Bandello F, Lafuma A, Berdeaux G.
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):96-103. PubMed ID: 17197522
    [Abstract] [Full Text] [Related]

  • 22. Reduced vision in older adults with age related macular degeneration interferes with ability to care for self and impairs role as carer.
    Stevenson MR, Hart PM, Montgomery AM, McCulloch DW, Chakravarthy U.
    Br J Ophthalmol; 2004 Sep; 88(9):1125-30. PubMed ID: 15317701
    [Abstract] [Full Text] [Related]

  • 23. Visual loss and visual hallucinations in patients with age-related macular degeneration (Charles Bonnet syndrome).
    Abbott EJ, Connor GB, Artes PH, Abadi RV.
    Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1416-23. PubMed ID: 17325191
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Vision-related quality of life in patients suffering from age-related macular degeneration.
    Berdeaux GH, Nordmann JP, Colin E, Arnould B.
    Am J Ophthalmol; 2005 Feb; 139(2):271-9. PubMed ID: 15733988
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Visual impairment, visual functioning, and quality of life assessments in patients with glaucoma.
    Parrish RK.
    Trans Am Ophthalmol Soc; 1996 Feb; 94():919-1028. PubMed ID: 8981717
    [Abstract] [Full Text] [Related]

  • 31. Author response: Validation of the National Eye Institute Visual Function Questionnaire-25 (NEIVFQ-25) in age-related macular degeneration.
    Orr P, Rentz AM, Margolis MK, Revicki DA, Dolan CM, Colman S, Fine JT, Bressler NM.
    Invest Ophthalmol Vis Sci; 2012 Dec 03; 53(13):7950. PubMed ID: 23208790
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Psychological and cognitive determinants of vision function in age-related macular degeneration.
    Rovner BW, Casten RJ, Massof RW, Leiby BE, Tasman WS, Wills Eye AMD Study.
    Arch Ophthalmol; 2011 Jul 03; 129(7):885-90. PubMed ID: 21746979
    [Abstract] [Full Text] [Related]

  • 38. Effect of vitrectomy for epiretinal membrane on visual function and vision-related quality of life.
    Okamoto F, Okamoto Y, Hiraoka T, Oshika T.
    Am J Ophthalmol; 2009 May 03; 147(5):869-74, 874.e1. PubMed ID: 19200531
    [Abstract] [Full Text] [Related]

  • 39. Relationship between visual impairment and eye diseases and visual function in Andhra Pradesh.
    Nutheti R, Keeffe JE, Shamanna BR, Nirmalan PK, Krishnaiah S, Thomas R.
    Ophthalmology; 2007 Aug 03; 114(8):1552-7. PubMed ID: 17678693
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 5.